Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | GLB1 | P16278 | 1/20 | 0.44 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | CTSS | P25774 | 1/20 | 0.42 |
| ▸ | CTSK | P43235 | 1/20 | 0.42 |
| ▸ | CTSC | P53634 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL8049457 | 0.86 | TDP1 (0.50) | TDP1GLB1GBA2GRIN2BMAOA | |
| SCHEMBL16499700 | 0.84 | MAOA (0.50) | TDP1MAOAMAOBCTSLCTSB | |
| SCHEMBL16499614 | 0.84 | MAOA (0.50) | TDP1MAOAMAOBCTSLCTSB | |
| SCHEMBL16499615 | 0.84 | MAOA (0.50) | TDP1MAOAMAOBCTSLCTSB | |
| SCHEMBL11959525 | 0.82 | GRIN2B (0.44) | TDP1GRIN2BMAOAMAOBCTSL | |
| SCHEMBL8049451 | 0.79 | GRIN2B (0.39) | GRIN2B | |
| SCHEMBL15684283 | 0.77 | S1PR1 (0.50) | GRIN2BMAOAMAOB | |
| SCHEMBL1609623 | 0.76 | MAOA (0.58) | MAOAMAOBCTSLCTSBCTSS | |
| SCHEMBL16405138 | 0.76 | SLC6A2 (0.47) | GRIN2BMAOAMAOBCTSLCTSB | |
| Ammonia Solution, Strong SCHEMBL9408795 | 0.76 | ACHE (0.44) | MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023141571-A1 | CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS | PRELUDE THERAPEUTICS, INCORPORATED (US) | 2023-07-27 | — | — | WO | disclosed |